Zeng more than $2.5 billion of the first blood lipid regulator Hunan Pharmaceutical Company will take the first imitation.

Pharmaceutical network September 9th, a few days ago, Hunan Fangsheng Pharmaceuticals to copy the 4 categories of reported wheat cereal tablets into the administrative approval stage, the original research products have been sold more than 2.5 billion U.S. dollars a year, the current domestic market has not been generic drugs listed for sale.
2019, sales of wheat chips at the end of China's public medical institutions exceeded 500 million yuan, up 50.76 percent year-on-year, according to the company's internal network data.
source: The State Drug Administration's official website developed by Shilling Yuya (has been acquired by Mercadon) of the E-fold wheat cloth was first approved by the FDA in October 2002, is the world's first cholesterol absorption inhibitor, it can selectively inhibit small intestine cholesterol transport protein, effectively reduce intestinal cholesterol absorption, reduce plasma cholesterol levels and liver cholesterol reserves, clinically mainly used to treat primary hypercholesterolemia.
Figure 1: Mercedon's global sales of U.S. dollars (in millions of U.S. dollars) Source: Milnet's multinational publicly traded company quickly became a heavy bomb-grade drug after it went public, with global sales toping $2 billion for the first time in 2007 and remaining around $2.5 billion since then.
with the patent expiring, sales of the product were "slashed" in 2017, with global sales of $590 million in 2019. according to
meters of intranet data, the domestic market is currently only in the domestic market, the sales of yiyi wheat cloth tablets listed on the market, in 2019 in China's urban public hospitals, county-level public hospitals, urban community centers and township hospitals (China's public medical institutions) terminal sales exceeded 500 million yuan, an increase of 50.76 percent year-on-year.
Figure 2: According to the new classification of folding wheat cloth film reported production source: Mi Net one-click search currently has 4 domestic pharmaceutical companies to copy 4 categories to submit the application for the listing of folding wheat cloth tablets, Hunan Fangsheng Pharmaceuticals in March 2019 the first production, September 2, 2020 into the administrative approval stage, is expected to be approved in recent days with the first imitation of the listing.
source: Mi Net database, State Drug Administration Note: statistics as of September 8, if there are omissions, welcome to point out!